Overview Request Sample Pages Request Customization Download PDF
You are viewing: South Korea Digital Pathology Market analysis
Part of: Digital Pathology Market (Global)

The South Korea Digital Pathology Market was valued at $22.6 Million in 2026 and projected to reach to $41.7 Million by 2031, representing a compound annual growth rate of 13.1%. South Korea's digital pathology market is positioned for sustained growth through 2031, driven by the nation's advanced healthcare ecosystem and strong emphasis on medical technology innovation.

South Korea Digital Pathology Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

South Korea Digital Pathology Market Trends and Insights

  • This growth trajectory reflects South Korea's advanced healthcare infrastructure and increasing adoption of digital diagnostic technologies across pathology laboratories and medical institutions.
  • South Korea's commitment to healthcare innovation and digital transformation is driving demand for whole slide imaging systems, AI-powered diagnostic tools, and cloud-based pathology solutions. The market in South Korea is supported by strong government initiatives promoting digital health adoption, rising prevalence of chronic diseases requiring pathological analysis, and growing investments in healthcare IT infrastructure.
  • South Korea's pathology sector is increasingly integrating digital workflows to improve diagnostic accuracy, reduce turnaround times, and enable remote consultation capabilities.
  • By 2031, South Korea is expected to solidify its position as a key digital pathology hub in the Asia Pacific region, with healthcare providers prioritizing modernization of laboratory operations and adoption of next-generation diagnostic platforms..

Key Market Statistics

  • CAGR (2026-2031) 13.1% CAGR
  • Market Size, 2026 ~USD 22.6 Million
  • Forecast, 2031 ~USD 41.7 Million
  • Country South Korea

South Korea Digital Pathology Market Overview

Rapid Market Expansion :

South Korea's digital pathology market is projected to grow from $22.6 million in 2026 to $41.7 million by 2031, representing a robust 13.1% CAGR, outpacing the global average of 12.5%.

Advanced Healthcare Infrastructure :

South Korea's state-of-the-art medical facilities and high digital adoption rates among pathology laboratories are driving accelerated implementation of digital diagnostic solutions across the nation.

Government Healthcare Innovation Support :

South Korea's strategic commitment to healthcare digitalization and investment in medical technology infrastructure creates a favorable environment for digital pathology solution providers and vendors.

Increasing Laboratory Digitalization :

Major medical institutions and pathology laboratories across South Korea are actively transitioning from traditional microscopy to digital pathology systems, enhancing diagnostic accuracy and operational efficiency.

South Korea Digital Pathology Market Dynamics

  • The country's high healthcare spending, coupled with increasing demand for efficient diagnostic solutions, creates significant opportunities for digital pathology adoption across both public and private medical institutions. The market will benefit from South Korea's aging population requiring enhanced diagnostic capabilities, growing collaboration between healthcare providers and technology vendors, and continuous improvements in digital imaging and AI-powered pathology solutions.
  • Strategic investments in healthcare infrastructure modernization and regulatory support for digital health technologies will further accelerate market penetration and establish South Korea as a regional leader in digital pathology adoption..

Related Ecosystem

Healthcare Analytics

Top Technologies
    Top Companies

      Healthcare It

      Top Technologies
        Top Companies

          Key Takeaways

          • South Korea's digital pathology market is valued at $22.6 million in 2026 and is forecast to grow to $41.7 million by 2031, representing a 13.1% CAGR.
          • South Korea's advanced healthcare infrastructure and government digital health initiatives are primary drivers of market expansion and technology adoption.
          • South Korea's pathology laboratories are increasingly implementing whole slide imaging and AI-powered diagnostic solutions to enhance operational efficiency and diagnostic accuracy.
          • South Korea is positioned as a regional leader in digital pathology adoption within Asia Pacific, supported by strong healthcare IT investments and modernization efforts.

          Digital Pathology Market Report Scope

          Report Metric Details
          Base Year 2026
          Fastest Growing Segment PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES (End User)
          Forecast Period 2026–2031
          Growth Rate CAGR of 12.5% from 2026 to 2031
          Largest Segment ONCOLOGY (Therapeutic Area)
          Market Size Base Year (Billions) ~USD 1.59 (2026)
          Revenue Forecast (Billions) ~USD 2.86 (2031)
          Segments Covered Product, Type, Technology, Application, Therapeutic Area, End User

          South Korea Digital Pathology Market Report Segmentation

          6 segment dimensions are covered across the global market.

          By Product

          • Hardware
          • Software
          • Storage Systems

          By Type

          • AI & Computational Pathology Software
          • Biomarker Discovery & Validation
          • Brightfield Scanners
          • Cloud Storage
          • Drug Discovery & Efficacy Studies
          • Enterprise Digital Pathology Solutions/Platforms
          • Fluorescence Scanners
          • Human Pathology
          • Hybrid Storage
          • Image Analysis Software
          • Image Management Software
          • On-Premise Storage
          • Other Pre-Clinical Research
          • Other Scanners
          • Peripherals & Accessories
          • Toxicology & Safety Assessment
          • Veterinary Pathology
          • Whole Slide Imaging Scanners
          • Workstations & Viewing Systems

          By Technology

          • AI-Enabled Digital Pathology
          • Conventional Digital Pathology

          By Application

          • Academic & Translational Research
          • Clinical Diagnostics
          • Clinical Trials
          • Education & Training
          • Other Applications
          • Pre-Clinical Research
          • Telepathology

          By Therapeutic Area

          • Gastrointestinal Disease
          • Hematology
          • Infectious Disease
          • Neurology
          • Oncology
          • Other Therapeutic Areas

          By End User

          • Academic & Research Institutes
          • Contract Research Organizations
          • Diagnostic & Reference Laboratories
          • Hospitals & Health Systems
          • Other End Users
          • Pharmaceutical & Biotechnology Companies
          • Veterinary Laboratories

          Target Audience

          • Digital Pathology Solution Vendors : Vendors need South Korea-specific market data to identify growth opportunities, understand local competition, and develop localized product strategies for this high-growth Asian market.
          • Healthcare IT Investors : Investors require detailed South Korea market analysis to evaluate investment opportunities in digital pathology companies and healthcare technology providers operating in this expanding market.
          • Medical Device Manufacturers : Manufacturers need insights into South Korean pathology laboratory requirements, procurement preferences, and technology adoption timelines to optimize product development and market entry strategies.
          • Healthcare Consulting Firms : Consultants advising healthcare institutions and technology companies require South Korea-specific market intelligence to develop informed strategic recommendations and implementation roadmaps.
          • Hospital & Laboratory Administrators : Decision-makers at South Korean medical institutions need market data to evaluate digital pathology investments, benchmark against peers, and justify technology modernization initiatives.

          Key Companies in the South Korea Digital Pathology Market

          CompanyHQOwnershipStrongest segments
          NIKON CORPORATIONJapanPublic CompanyImaging Business (digital cameras and cinema cameras),Precision Equipment Business (FPD exposure equipment),Healthcare Business (life science solutions),
          PIXCELLDATAIsraelPrivate CompanyCore data/analytics platform subscriptions,Professional services & implementation,Value-added modules & advanced analytics,
          SUNQUEST INFORMATION SYSTEMSUnited StatesPrivate CompanyCore LIS (Sunquest Laboratory, Multi-Lab Networking, Collect),Pathology and Anatomic Pathology (PowerPath, CoPathPlus),Blood Bank and Transfusion Management,
          CERNER CORPORATIONUnited StatesPrivate CompanyCerner Millennium and core clinical/financial applications,HealtheIntent population health and data platform,CareAware and device connectivity solutions,
          ZENSAR TECHNOLOGIES LTDIndiaPublic CompanyDigital and Application Services,Cloud Infrastructure and Security,Experience, Brand, and Creative Services,
          DANAHER CORPORATIONUnited StatesPublic CompanyBiotechnology (bioprocessing, single-use, cell culture, filtration),Life Sciences (genomics, mass spec, imaging, lab automation),Diagnostics (clinical instruments, consumables, software),
          KONINKLIJKE PHILIPS N.V.NetherlandsPublic CompanyDiagnosis & Treatment (Imaging and Image-Guided Therapy),Connected Care (Monitoring, Enterprise Informatics, Sleep & Respiratory Care),Personal Health,
          SECTRA ABSwedenPublic CompanyImaging IT Solutions,Secure Communications,Business Innovation (orthopedics, education, precision diagnostics),
          HAMAMATSU PHOTONICS K.K.JapanPublic CompanyElectron Tube (incl. photomultiplier tubes and radiation/x-ray sensors),Opto-Semiconductor (photodiodes, APDs, SPADs, MPPC, UV/IR sensors),Imaging and Measurement Instruments (cameras, spectrometers, x-ray systems, software),
          QUANTERIX CORPORATIONUnited StatesPublic CompanyHD-X instrument and related assays/consumables,SR-X instrument and related assays/consumables,SP-X planar array platform and multiplex assays,
          FUJIFILM HOLDINGS CORPORATIONJapanPublic CompanyHealthcare (medical systems, CDMO, pharma, regenerative, cosmetics),Business Innovation (office, document solutions, graphic communications),Electronics (display, semiconductor materials, storage, industrial equipment),
          HOLOGIC, INC.United StatesPrivate CompanyDiagnostics (Aptima, Panther, ThinPrep, Rapid Fetal Fibronectin),Breast Health (3D mammography, biopsy, localization, treatment support),GYN Surgical (MyoSure, NovaSure, Fluent, Acessa, CoolSeal),
          AIFORIAFinlandPublic CompanyClinical AI suite (viewer + cancer diagnostics),Aiforia Create (AI model development platform),Services, customization, and other software,

          NIKON CORPORATION

          Nikon Corporation is a Japanese public company founded in 1917 with 19,928 employees, known for manufacturing imaging and optical products.

          PIXCELLDATA

          Pixcelldata is a private company founded in 2010 and based in Israel.

          SUNQUEST INFORMATION SYSTEMS

          Sunquest Information Systems is a private company founded in 1979 and based in the United States.

          CERNER CORPORATION

          Cerner Corporation is a private company founded in 1979 in the United States with 25,150 employees, specializing in healthcare information technology.

          ZENSAR TECHNOLOGIES LTD

          Zensar Technologies Ltd is an Indian public company founded in 1963 with 10,066 employees, providing IT services and solutions.

          DANAHER CORPORATION

          Danaher Corporation is a public company founded in 1969 in the United States with 59,000 employees, operating as a diversified conglomerate.

          KONINKLIJKE PHILIPS N.V.

          Koninklijke Philips N.V. is a Dutch public company founded in 1891 with 64,317 employees, operating as a global diversified technology corporation.

          SECTRA AB

          Sectra AB is a Swedish public company founded in 1957 with 1,365 employees, specializing in medical imaging and cybersecurity solutions.

          HAMAMATSU PHOTONICS K.K.

          Hamamatsu Photonics K.K. is a Japanese public company founded in 1953 with 6,601 employees, manufacturing photonic products and systems.

          QUANTERIX CORPORATION

          Quanterix Corporation is a public company founded in 2007 in the United States with 450 employees, specializing in biotech instrumentation.

          FUJIFILM HOLDINGS CORPORATION

          Fujifilm Holdings Corporation is a Japanese public company founded in 1934 with 73,526 employees, operating across imaging, healthcare, and materials sectors.

          HOLOGIC, INC.

          Hologic, Inc. is a private company founded in 1985 in the United States with 7,070 employees, specializing in medical diagnostics and imaging.

          AIFORIA

          Aiforia is a Finnish public company founded in 2013 with 76 employees, specializing in artificial intelligence solutions.

          Reasons to Buy this Report

          • Market-Specific Growth Projections : Access detailed forecasts showing South Korea's digital pathology market expanding at 13.1% CAGR through 2031, enabling precise investment and expansion planning tailored to this high-growth market.
          • Competitive Landscape Intelligence : Understand South Korea's unique competitive dynamics, key market players, and institutional adoption patterns specific to Korean pathology laboratories and medical centers.
          • Regulatory & Healthcare Policy Insights : Gain comprehensive understanding of South Korea's healthcare regulations, reimbursement frameworks, and government initiatives supporting digital pathology implementation and technology adoption.
          • Regional Market Entry Strategy : Develop targeted go-to-market strategies for South Korea with insights into local healthcare procurement processes, institutional preferences, and partnership opportunities with Korean medical institutions.
          • Technology Adoption Trends : Identify emerging technology preferences, integration requirements, and digital transformation priorities specific to South Korean pathology laboratories and healthcare providers.

          Frequently asked questions

          What is the current size of South Korea's digital pathology market?

          South Korea's digital pathology market is valued at $22.6 million in 2026 and is expected to grow at a 13.1% CAGR through 2031.

          What is the projected market size for digital pathology in South Korea by 2031?

          South Korea's digital pathology market is projected to reach $41.7 million by 2031, representing significant growth from the 2026 baseline.

          What factors are driving digital pathology adoption in South Korea?

          South Korea's market growth is driven by advanced healthcare infrastructure, government digital health initiatives, rising chronic disease prevalence, and healthcare provider investments in laboratory modernization.

          How does South Korea's digital pathology market compare to other Asia Pacific countries?

          South Korea is positioned as a regional leader in digital pathology adoption, supported by strong healthcare IT infrastructure, government support, and high technology adoption rates among medical institutions.

          What technologies are being adopted in South Korea's digital pathology market?

          South Korea's pathology sector is increasingly adopting whole slide imaging systems, AI-powered diagnostic tools, cloud-based pathology solutions, and remote consultation platforms to modernize laboratory operations.

          RESEARCH METHODOLOGY

          This research study involved the extensive use of both primary and secondary sources. It involved the analysis of various factors affecting the industry to identify the segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

          Secondary Research

          This research study extensively utilized secondary sources, including directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, as well as white papers, annual reports, and companies' house documents. The secondary research aimed to gather and analyze information for a comprehensive and commercially focused study of the digital pathology market, encompassing technical aspects and market dynamics. It also facilitated the identification of key players, market classification, industry trends, geographical markets, and significant market-related developments. Additionally, a database of prominent industry leaders was compiled through secondary research.

          Primary Research

          In the primary research process, various supply-side and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, engineers, and related key executives from various companies and organizations operating in the digital pathology market. Primary sources from the demand side included personnel from pharmaceutical & biotechnology companies, hospitals, diagnostic laboratories, and academic & research institutes.

          Digital Pathology Market Size, and Share

          *Others include sales managers, marketing managers, and product managers.

          Note: Tiers are defined based on a company’s total revenue as of 2025: Tier 1 = > USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.

          To know about the assumptions considered for the study, download the pdf brochure

          Market Size Estimation

          The total size of the digital pathology market was determined through data triangulation using the two approaches described below. After completing each approach, a weighted average was calculated based on the level of assumptions used in each approach.

          Digital Pathology Market Top Down and Bottom Up Approach

          Data Triangulation

          The size of the digital pathology market was estimated through segmental extrapolation using the bottom-up approach. The methodology used is as follows: -

          • Revenues for individual companies were gathered from public sources and databases.
          • Shares of leading players in the digital pathology market were gathered from secondary sources to the extent available. In certain cases, shares of digital pathology businesses have been determined through a detailed analysis of various parameters, including product portfolios, market positioning, selling prices, and geographic reach & strength. 
          • Individual shares or revenue estimates were validated through interviews with experts.
          • The total revenue in the digital pathology market was determined by extrapolating the market share data of major companies.

          Market Definition

          Digital pathology is an image-based information environment for managing and interpreting information generated from digitized glass slides. The process involves converting glass slides to digital pathology slides using digital pathology scanning solutions. A digital image is then generated, enabling high-resolution slide viewing.

          Key Stakeholders

          • Healthcare Institutions/Providers (Hospitals, Medical Groups, Physician Practices, Diagnostic Centers, Ambulatory Centers, and Outpatient Clinics)
          • Digital Pathology Organizations
          • Senior Management
          • Finance/Procurement Department
          • R&D Department
          • Healthcare Data Aggregators
          • Venture Capitalists
          • Government Agencies
          • Healthcare Startups, Consultants, and Regulators
          • Academic Medical Institutes

          Report Objectives

          • To define, describe, and forecast the digital pathology market based on product, type, technology, application, therapeutic area, end user, and region
          • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
          • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall digital pathology market
          • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
          • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa.
          • To profile the key players and analyze their market shares and core competencies2
          • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, and collaborations in the overall digital pathology market
          • To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

          Available customizations:

          With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

          Company Information

          • Detailed analysis and profiling of additional market players (up to 5)

          Geographic Analysis

          • Further breakdown of the Rest of Asia Pacific digital pathology market into Taiwan, New Zealand, Thailand, Singapore, Malaysia, and other countries
          • Further breakdown of the Rest of Europe digital pathology market into Russia, Austria, Finland, Turkey, Norway, Poland, Portugal, Romania, Denmark, and other countries

           

          Get the Full Digital Pathology Market Report

          Full forecast, segment splits, and company analysis for all Digital Pathology Market.

          Download Sample Pages Buy Report

          METHODOLOGY

          Need a Tailored Report?

          Customize this report to your needs

          Get 10% FREE Customization

          Customize This Report
          Fact checked
          Cite this Research
          DMCA.com Protection Status